Optimising the use of the tripeptide feG for treatment of RSV bronchiolitis and subsequent airway hypersensitivity.

Chief Investigator: A/Prof Dani-Louise Dixon Funding Amount : $99,973 Recipient: Flinders University Overview: Bronchiolitis, the most common severe respiratory tract illness in infants, remains a major cause of hospitalisation in Australia. Currently, there